Gabapentin and Nausea and vomiting for Girls aged 2-9 (a phase IV clinical study of FDA data)

Summary:

Nausea and vomiting is found for girls aged 2-9 who take Gabapentin (gabapentin). This study is created by eHealthMe based on reports of 461 girls aged 2-9 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Gabapentin when people have Nausea and vomiting
Top conditions
Top co-used drugs
Top other side effects

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

461 girls aged 2-9 reported to have side effects when taking Gabapentin.
Among them, 34 people (7.38%) have Nausea and vomiting

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Nausea and vomiting?

Nausea and vomiting is found to be associated with 3,712 drugs and 5,745 conditions by eHealthMe. Check the latest studies of Nausea and vomiting.

Number of reports submitted per year:

Could Gabapentin cause Nausea and vomiting in girls aged 2-9?

Severity of Nausea and vomiting

n/a

How people recovered from Nausea and vomiting

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 11.76%
Neuroblastoma (a cancer that forms in your nerve tissue): 4 people, 11.76%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 8.82%
Haemochromatosis (body to absorb more iron than usual from food): 2 people, 5.88%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.88%
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 2 people, 5.88%
Oral Pain: 2 people, 5.88%
Fever: 2 people, 5.88%
Urinary Tract Infection: 2 people, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Hypotension (abnormally low blood pressure): 14 people, 41.18%
Diarrhea: 13 people, 38.24%
Nausea (feeling of having an urge to vomit): 10 people, 29.41%
Fever: 8 people, 23.53%
Abdominal Pain: 7 people, 20.59%
Oxygen Saturation Decreased: 7 people, 20.59%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 20.59%
Arrhythmias (irregular heartbeat): 7 people, 20.59%
Drowsiness: 6 people, 17.65%
Mydriasis (a dilation of the pupil): 6 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Nausea and vomiting?

- Check whether Nausea and vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

Related studies:

Gabapentin and Nausea and vomiting

How the study uses the data?

The study is based on (applicable) gender, age, gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.